Form 144 - Report of proposed sale of securities:
SEC Accession No. 0002002698-24-000419
Filing Date
2024-09-16
Accepted
2024-09-16 14:30:25
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4029
  Complete submission text file 0002002698-24-000419.txt   5429
Mailing Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116
Business Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116 801-584-3600
MYRIAD GENETICS INC (Subject) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 000-26642 | Film No.: 241300743
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116
Business Address
Ancona Margaret (Reporting) CIK: 0001843568 (see all company filings)

Type: 144